Hartmann A - Search Results

1

Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma.

Agaimy A, Clarke BA, Kolin DL, Lee CH, Lee JC, McCluggage WG, Pöschke P, Stoehr R, Swanson D, Turashvili G, Beckmann MW, Hartmann A, Antonescu CR, Dickson BC. Agaimy A, et al. Among authors: hartmann a. Am J Surg Pathol. 2022 Sep 1;46(9):1298-1308. doi: 10.1097/PAS.0000000000001915. Epub 2022 May 17. Am J Surg Pathol. 2022. PMID: 35575789 Free PMC article.

2

No evidence for involvement of beta-catenin and APC in urothelial carcinomas.

Stoehr R, Krieg RC, Knuechel R, Hofstaedter F, Pilarsky C, Zaak D, Schmitt R, Hartmann A. Stoehr R, et al. Among authors: hartmann a. Int J Oncol. 2002 May;20(5):905-11. Int J Oncol. 2002. PMID: 11956582

3

Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies.

Hafner C, Knuechel R, Stoehr R, Hartmann A. Hafner C, et al. Among authors: hartmann a. Int J Cancer. 2002 Sep 1;101(1):1-6. doi: 10.1002/ijc.10544. Int J Cancer. 2002. PMID: 12209580 Review.

4

Histologic-genetic mapping by allele-specific PCR reveals intraurothelial spread of p53 mutant tumor clones.

Stoehr R, Knuechel R, Boecker J, Blaszyk H, Schmitt R, Filbeck T, Hofstaedter F, Hartmann A. Stoehr R, et al. Among authors: hartmann a. Lab Invest. 2002 Nov;82(11):1553-61. doi: 10.1097/01.lab.0000035022.29742.85. Lab Invest. 2002. PMID: 12429815 Free article.

5

Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.

Obermann EC, Junker K, Stoehr R, Dietmaier W, Zaak D, Schubert J, Hofstaedter F, Knuechel R, Hartmann A. Obermann EC, et al. Among authors: hartmann a. J Pathol. 2003 Jan;199(1):50-7. doi: 10.1002/path.1259. J Pathol. 2003. PMID: 12474226

6

Low frequency of human polyomavirus BKV and JCV DNA in urothelial carcinomas of the renal pelvis and renal cell carcinomas.

Knöll A, Stoehr R, Jilg W, Hartmann A. Knöll A, et al. Among authors: hartmann a. Oncol Rep. 2003 Mar-Apr;10(2):487-91. Oncol Rep. 2003. PMID: 12579294

7

Lasermicrodissection--an important prerequisite for the molecular-genetic analysis of bladder cancer.

Stoehr R, Wild P, Hartmann A. Stoehr R, et al. Among authors: hartmann a. Pathol Res Pract. 2003;199(6):355-62. doi: 10.1078/0344-0338-00431. Pathol Res Pract. 2003. PMID: 12924435

8

WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer.

Wissmann C, Wild PJ, Kaiser S, Roepcke S, Stoehr R, Woenckhaus M, Kristiansen G, Hsieh JC, Hofstaedter F, Hartmann A, Knuechel R, Rosenthal A, Pilarsky C. Wissmann C, et al. Among authors: hartmann a. J Pathol. 2003 Oct;201(2):204-12. doi: 10.1002/path.1449. J Pathol. 2003. PMID: 14517837

9

Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer.

Stoehr R, Wissmann C, Suzuki H, Knuechel R, Krieg RC, Klopocki E, Dahl E, Wild P, Blaszyk H, Sauter G, Simon R, Schmitt R, Zaak D, Hofstaedter F, Rosenthal A, Baylin SB, Pilarsky C, Hartmann A. Stoehr R, et al. Among authors: hartmann a. Lab Invest. 2004 Apr;84(4):465-78. doi: 10.1038/labinvest.3700068. Lab Invest. 2004. PMID: 14968126 Free article.

10

RNA expression profiling of normal and tumor cells following photodynamic therapy with 5-aminolevulinic acid-induced protoporphyrin IX in vitro.

Wild PJ, Krieg RC, Seidl J, Stoehr R, Reher K, Hofmann C, Louhelainen J, Rosenthal A, Hartmann A, Pilarsky C, Bosserhoff AK, Knuechel R. Wild PJ, et al. Among authors: hartmann a. Mol Cancer Ther. 2005 Apr;4(4):516-28. doi: 10.1158/1535-7163.MCT-04-0141. Mol Cancer Ther. 2005. PMID: 15827324

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,403 results

Search Page